Key result
Higher glycemic variability is linked to ~93% greater risk of myocardial infarction.
Why the study?
The association between glycemic variability and cardiovascular complications, specifically myocardial infarction, remains controversial.
Is glycemic variability associated with the risk of myocardial infarction?
Meta-Analysis (n=109,058)
Is glycemic variability associated with the risk of myocardial infarction?
Odds Ratio: 1.93 (95% CI 1.08–3.44)
p-value: p=0.03
Glycemic variability is significantly associated with myocardial infarction, suggesting that fluctuations in plasma glucose may contribute to cardiovascular risk.
Diabetes mellitus is a major risk factor for vascular complications and mortality, glycemic variability (GV) has emerged as a measure of time and magnitude of plasma glucose, its association with cardiovascular complications is controversial. The current study aimed to assess the association of GV with myocardial infarction. An electronic literature search was conducted in PubMed, Medline, and Google Scholar databases for relevant articles. Articles in the English language during the period from 2010 to April 2020 were eligible. The keywords fasting blood glucose variability (FBGV), glucose variability, myocardial infarction, and acute coronary syndrome, were used with the protean OR and AND. Out of the 185 articles retrieved, only seven full texts fulfilled the inclusion and exclusion criteria. The author's name, year of publication, the study type, number of patients, and the results were extracted. There were seven full texts, one from Brazil, one from Australia, two from the USA, and three from Asia. Two were randomized controlled trials and five were prospective cohorts (included 109,058 participants). A significant negative association was found between GV and myocardial infarction, odd ratio (OD) 1.93, 95% CI=1.08-3.44, P-value=0.03, I2 for heterogeneity=87%, P-value=0.0001. However, it is difficult to reach a conclusion due to the small number of the included studies and the high heterogeneity observed. Further well-controlled trials using the same methods are needed to resolve the issue.
No takes yet. Share an insight, caveat, or question.
Alatawi et al. (2020) conducted a meta-analysis in Myocardial infarction (n=109,058). Glycemic variability vs. Lower glycemic variability was evaluated on Myocardial infarction (OR 1.93, 95% CI 1.08-3.44, p=0.03). Glycemic variability was significantly associated with an increased risk of myocardial infarction (OR 1.93).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: